This is a preview of subscription content, log in via an institution to check access.
Notes
Comparative Effectiveness Public Advisory Council
References
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Releases Draft Evidence Report on Inotersen and Patisiran for Hereditary Transthyretin Amyloidosis Internet Document : 20 Jul 2018. Available from: URL: https://icer-review.org/announcements/amyloidosis-draft-report/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review to Evaluate Comparative Clinical Effectiveness and Value of AVXS-101 and Nusinersen for Spinal Muscular Atrophy. Internet Document : 31 Jul 2018. Available from: URL: https://icer-review.org/announcements/sma-topic-announcement/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Updated Report on Targeted Treatments for Plaque Psoriasis Finds Guselkumab and Risankizumab Offer Superior Health Benefit Compared with TNF-alpha Inhibitors Internet Document : 3 Aug 2018. Available from: URL: https://icer-review.org/announcements/psoriasis-final-condition-update/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Final Report Highlights Limitations in Evidence on Long-term Safety and Effectiveness of Elagolix for Endometriosis, Discusses Options for Insurance Coverage Criteria Internet Document : 3 Aug 2018. Available from: URL: https://icer-review.org/announcements/elagolix-final-report/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Lists Potential Options for Assessments in 2019 Internet Document : 2 Aug 2018. Available from: URL: https://icer-review.org/announcements/2019-potential-topics/.
Rights and permissions
About this article
Cite this article
Recent news from ICER. PharmacoEcon Outcomes News 809, 4–5 (2018). https://doi.org/10.1007/s40274-018-5156-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5156-z